ISO/DTS 16766

This draft is in the approval phase.

Abstract

This document provides guidance to manufacturers on the minimal considerations for in vitro diagnostic (IVD) medical devices in a public health crisis: - general considerations; - risk reduction; - monitoring the devices’ post-market performance and quality assurance; - implementing a communication system. This document does not supersede the existing traditional regulatory authorization requirements for IVD medical devices available in the marketplace.

General information

Status
: Under development

Stage
: Proof sent to secretariat or FDIS ballot initiated: 8 weeks [50.20]
Edition
: 1

Number of pages
: 13
Technical Committee :
ISO/TC 212

ICS :
11.100.10
RSS updates